FDA narrows drug label usage

被引：0

|

作者：

Elie Dolgin

机构：

来源：

Nature | 2009年 / 460卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Cancer treatments limited to specific gene variants.

引用

收藏

页码：1069 / 1069

相关论文

共 50 条

[31] FDA lifts olestra warning label
Walsh, K
CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
[32] FDA eases label claim regulation
不详
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1998, 98 (08) : 855 - 855
[33] No FDA warning label for doxazosin as yet
Reactions Weekly, 2001, 856 (1) : 2 - 2
[34] FDA and Drug Shortages
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (06): : 553 - 553
[35] DRUG USAGE
不详
SCIENCE NEWS, 1984, 125 (13) : 195 - 195
[36] FDA and drug approval
Faich, GA
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
[37] DRUG SAFETY AND FDA
PISANI, JM
FOOD DRUG COSMETIC LAW JOURNAL, 1966, 21 (02): : 68 - 77
[38] DRUG DELAY AND THE FDA
BARRANCO, VP
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (10) : 691 - 692
[39] FDA AND DRUG COMPENDIA
BASSEN, JL
BEEK, CR
FDA PAPERS, 1972, 6 (04): : 19 - 23
[40] HOW FDA REVIEWS FLAVORS FOR SAFE USAGE
SMITH, M
FOOD ENGINEERING, 1980, 52 (05): : 124 - 125

← 1 2 3 4 5 →